Compare CXDO & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CXDO | ACB |
|---|---|---|
| Founded | 1995 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Pharmaceuticals and Biotechnology |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 196.9M | 232.3M |
| IPO Year | 1999 | 2016 |
| Metric | CXDO | ACB |
|---|---|---|
| Price | $5.91 | $3.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $10.92 | N/A |
| AVG Volume (30 Days) | 190.1K | ★ 1.1M |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 166.67 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $68,167,000.00 | N/A |
| Revenue This Year | $42.60 | N/A |
| Revenue Next Year | $13.69 | $8.67 |
| P/E Ratio | $111.00 | ★ N/A |
| Revenue Growth | ★ 12.05 | N/A |
| 52 Week Low | $5.35 | $2.56 |
| 52 Week High | $11.23 | $6.36 |
| Indicator | CXDO | ACB |
|---|---|---|
| Relative Strength Index (RSI) | 38.40 | 45.18 |
| Support Level | $5.55 | $3.75 |
| Resistance Level | $6.12 | $4.20 |
| Average True Range (ATR) | 0.20 | 0.17 |
| MACD | -0.03 | -0.05 |
| Stochastic Oscillator | 25.52 | 19.88 |
Crexendo Inc is a software technology company that provides cloud communication platform software and unified communications as a service (UCaaS) offering, including voice, video, contact center, and managed IT services. The company operates through two segments: Cloud Telecommunications Services and Software Solutions. Its cloud telecommunications segment generates revenue from the provision of broadband Internet services, managed IT services, software license sales, and infrastructure as a service. The software solutions segment derives revenues from three primary sources: software licenses, software maintenance support and professional services. The majority of the company's revenue is derived from the Cloud Telecommunications Services segment.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.